This paper examines Vancomycin-resistant Enterococci (VRE) as a case study in microbial antibiotic resistance. It provides background on Enterococci bacteria, their natural occurrence in the human body and environment, and their capacity to cause infection when present in large quantities. The paper then explains the mechanism by which bacteria develop resistance to antibiotics such as vancomycin — including the destruction of beneficial protective microbes and the survival of resistant strains — and concludes by underscoring the ongoing need for new antimicrobial treatments to address this growing public health challenge.
Healthcare is one of the most important disciplines in society. Without proper healthcare, all other functions of society cease to exist. As a result, a large amount of capital has been dedicated to the prevention, mitigation, or eradication of diseases throughout society. The recent COVID-19 pandemic illustrates how inadequate healthcare and treatment can undermine society as a whole. Vancomycin-resistant Enterococci (VRE) is no different in this regard, as it too can cause large-scale complications if left unchecked.
Enterococci are bacteria that occur naturally within the human body, primarily within the intestine. Enterococci bacteria are also common elements within soil and water. In larger quantities, Enterococci can cause infection and healthcare complications for individuals. These infections are typically treated with antibiotics such as vancomycin. However, the bacteria have been known to resist vancomycin and other treatment options. As a result, new healthcare solutions have been developed to combat the bacteria.
"How bacteria develop immunity to antibiotics"
"Cited peer-reviewed source"
Always verify citation format against your institution’s current style guide requirements.